• Deciphering genetic susceptibility to multiple myeloma 

  Went, M (2020-09-30)

  Multiple myeloma (MM) is a malignancy characterised by the clonal expansion of plasma cells primarily from the bone marrow. The two- to four-fold increased risk observed in relatives of MM patients provides support for ...
• Searching for treatments for non-G12C-KRAS mutant cancers. 

  Guo, C; Banerji, U (2021-04-15)

  KRAS mutations drive a wide variety of cancers. Drugs targeting the protein product of KRAS^G12C mutations are currently being evaluated show preliminary efficacy in clinical trials. A clinical trial of VS-6766, ...
• Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer. 

  Smyth, LM; Batist, G; Meric-Bernstam, F; Kabos, P; Spanggaard, I; Lluch, A; Jhaveri, K; Varga, A; Wong, A; Schram, AM; Ambrose, H; Carr, TH; de Bruin, EC; Salinas-Souza, C; Foxley, A; Hauser, J; Lindemann, JPO; Maudsley, R; McEwen, R; Moschetta, M; Nikolaou, M; Schiavon, G; Razavi, P; Banerji, U; Baselga, J; Hyman, DM; Chandarlapaty, S (2021-04-16)

  Five to ten percent of ER+ metastatic breast cancer (MBC) tumors harbor somatic PTEN mutations. Loss of function of this tumor-suppressor gene defines a highly aggressive, treatment-refractory disease for which new therapies ...
• Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche. 

  Müller, LME; Migneco, G; Scott, GB; Down, J; King, S; Askar, B; Jennings, V; Oyajobi, B; Scott, K; West, E; Ralph, C; Samson, A; Ilett, EJ; Muthana, M; Coffey, M; Melcher, A; Parrish, C; Cook, G; Lawson, M; Errington-Mais, F

  <h4>Background</h4>Multiple myeloma (MM) remains an incurable disease and oncolytic viruses offer a well-tolerated addition to the therapeutic arsenal. Oncolytic reovirus has progressed to phase I clinical trials and its ...
• Circulating microRNA-652-3p as a biomarker of regorafenib resistance in metastatic colorectal cancer patients 

  Hedayat-Husseyin, S (2020-09-30)

  MicroRNAs (miRNAs) are small non-coding RNAs involved in cell homeostasis. MiRNAs dysregulation has been linked with activation of oncogenic pathways, cancer progression and clinical outcome in metastatic colorectal cancer ...
• Deciphering the genomic landscape and evolution in multiple myeloma 

  Hoang, P (2020-09-30)

  Multiple myeloma (MM) is the second commonest haematological cancer in Western countries, with most patients dying from progressive disease after relapse. Currently, the molecular mechanisms responsible for the initiation ...
• Investigating the molecular mechanisms of fraction size sensitivity in irradiated cells 

  McBay, D (2020-09-30)

  Fractionated radiotherapy is used clinically when it spares healthy tissue relative to the cancer; the healthy tissue is described as more fraction size sensitive. However, a molecular understanding of the mechanisms that ...
• Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer 

  Pacini, L; Jenks, AD; Lima, NC; Huang, PH

  <jats:p>Lung cancer is the most common cause of cancer-related deaths globally. Genetic alterations, such as amplifications, mutations and translocations in the fibroblast growth factor receptor (FGFR) family have been ...
• Taste dysfunction following radiotherapy to the head and neck: A systematic review. 

  Gunn, L; Gilbert, J; Nenclares, P; Soliman, H; Newbold, K; Bhide, S; Wong, KH; Harrington, K; Nutting, C

  <h4>Background</h4>An intact sense of taste provides pleasure, supports sustenance and alerts the body to toxins. Head and neck cancer (HNC) patients who receive radiotherapy (RT) are high-risk for developing radiation-induced ...
• Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma. 

  Bird, S; Panopoulou, A; Shea, RL; Tsui, M; Saso, R; Sud, A; West, S; Smith, K; Barwood, J; Kaczmarek, E; Panlaqui, C; Kaiser, M; Stern, S; Pawlyn, C; Boyd, K (2021-04-19)
• Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs. 

  Saavedra-García, P; Roman-Trufero, M; Al-Sadah, HA; Blighe, K; López-Jiménez, E; Christoforou, M; Penfold, L; Capece, D; Xiong, X; Miao, Y; Parzych, K; Caputo, VS; Siskos, AP; Encheva, V; Liu, Z; Thiel, D; Kaiser, MF; Piazza, P; Chaidos, A; Karadimitris, A; Franzoso, G; Snijders, AP; Keun, HC; Oyarzún, DA; Barahona, M; Auner, HW

  Cancer cells can survive chemotherapy-induced stress, but how they recover from it is not known. Using a temporal multiomics approach, we delineate the global mechanisms of proteotoxic stress resolution in multiple myeloma ...
• The use of germline genetic profiles to guide prostate cancer targeted screening and cancer care 

  Benafif, S (2020-09-30)

  The genetic heritability of prostate cancer is contributed to by rarely occurring but high penetrant genetic variants, and moderate to commonly occurring variants conferring lower risks. Genome wide association studies and ...
• Cancer progression: A journey through the past (with the same stops)? 

  Castillo, SP (2021-05-04)
• Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. 

  Vale, CL; Fisher, D; Kneebone, A; Parker, C; Pearse, M; Richaud, P; Sargos, P; Sydes, MR; Brawley, C; Brihoum, M; Brown, C; Chabaud, S; Cook, A; Forcat, S; Fraser-Browne, C; Latorzeff, I; Parmar, MKB; Tierney, JF; ARTISTIC Meta-analysis Group (2020-09-28)

  BACKGROUND:It is unclear whether adjuvant or early salvage radiotherapy following radical prostatectomy is more appropriate for men who present with localised or locally advanced prostate cancer. We aimed to prospectively ...
• Monitoring advances including consent: learning from COVID-19 trials and other trials running in UKCRC registered clinical trials units during the pandemic 

  Love, SB; Armstrong, E; Bayliss, C; Boulter, M; Fox, L; Grumett, J; Rafferty, P; Temesi, B; Wills, K; Corkhill, A

  <jats:title>Abstract</jats:title><jats:p>The COVID-19 pandemic has affected how clinical trials are managed, both within existing portfolios and for the rapidly developed COVID-19 trials. Sponsors or delegated organisations ...
• Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1 

  Cheeseman, M; Wilding, B; Pasqua, E; Chessum, N; Pierrat, O; Hahner, T; Tomlin, K; Shehu, E; Burke, R; Richards, M; Whitton, B; Arwert, E; Thapaliya, A; Salimraj, R; Van Montfort, R; Skawinska, A; Hayes, A; Raynaud, F; Chopra, R; Jones, K; Newton, G (2021-05-04)
• Single dose prostate radiotherapy - a step too far? 

  Tree, AC; van As, NJ (2021-04-21)
• ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology. 

  Corradini, S; Alongi, F; Andratschke, N; Azria, D; Bohoudi, O; Boldrini, L; Bruynzeel, A; Hörner-Rieber, J; Jürgenliemk-Schulz, I; Lagerwaard, F; McNair, H; Raaymakers, B; Schytte, T; Tree, A; Valentini, V; Wilke, L; Zips, D; Belka, C (2021-03-26)

  Online magnetic resonance-guided radiotherapy (oMRgRT) represents one of the most innovative applications of current image-guided radiation therapy (IGRT). The revolutionary concept of oMRgRT systems is the ability to ...
• Fracture risk in men with metastatic prostate cancer treated with radium-223 

  Hijab, A; Curcean, S; Tunariu, N; Tovey, H; Alonzi, R; Staffurth, J; Blackledge, MD; Padhani, AR; Tree, A; Stidwill, H; Finch, J; Chatfield, P; Perry, S; Koh, D; Hall, E; Parker, CC
• Cell-surface receptors enable perception of extracellular cytokinins. 

  Antoniadi, I; Novák, O; Gelová, Z; Johnson, A; Plíhal, O; Simerský, R; Mik, V; Vain, T; Mateo-Bonmatí, E; Karady, M; Pernisová, M; Plačková, L; Opassathian, K; Hejátko, J; Robert, S; Friml, J; Doležal, K; Ljung, K; Turnbull, C; Turnbull, C (2020-08-27)

  Cytokinins are mobile multifunctional plant hormones with roles in development and stress resilience. Although their Histidine Kinase receptors are substantially localised to the endoplasmic reticulum, cellular sites of ...

View more